United They Stand? Differing Device Platforms Share FDA Oversight Plank
This article was originally published in The Gray Sheet
Executive Summary
Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability